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Policy Points:
 Worldwide, more than 70% of all deaths are attributable to noncom-
municable diseases (NCDs), nearly half of which are premature and
apply to individuals of working age. Although such deaths are largely
preventable, effective solutions continue to elude the public health
community.
 One reason is the considerable influence of the “commercial deter-
minants of health”: NCDs are the product of a system that includes
powerful corporate actors, who are often involved in public health
policymaking.
 This article shows how a complex systems perspective may be used to
analyze the commercial determinants of NCDs, and it explains how
this can help with (1) conceptualizing the problem of NCDs and (2)
developing effective policy interventions.
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Context: The high burden of noncommunicable diseases (NCDs) is politically
salient and eminently preventable. However, effective solutions largely continue
to elude the public health community. Two pressing issues heighten this chal-
lenge: the first is the public health community’s narrow approach to addressing
NCDs, and the second is the involvement of corporate actors in policymaking.
While NCDs are often conceptualized in terms of individual-level risk factors,
we argue that they should be reframed as products of a complex system. This
article explores the value of a systems approach to understanding NCDs as an
emergent property of a complex system, with a focus on commercial actors.
Methods: Drawing on Donella Meadows’s systems thinking framework, this
article examines how a systems perspective may be used to analyze the com-
mercial determinants of NCDs and, specifically, how unhealthy commodity
industries influence public health policy.
Findings: Unhealthy commodity industries actively design and shape the
NCD policy system, intervene at different levels of the system to gain agency
over policy and politics, and legitimize their presence in public health policy
decisions.
Conclusions: It should be possible to apply the principles of systems thinking
to other complex public health issues, not just NCDs. Such an approach should
be tested and refined for other complex public health challenges.
Keywords: systems thinking, noncommunicable diseases, unhealthy com-
modity industries.
R eversing the high burden of noncommunicablediseases (NCDs) such as cardiovascular diseases, cancers, dia-betes, and mental illness is a key global health challenge. The
latest estimates by theWorldHealth Organization (WHO) indicate that
approximately 70% of all deaths worldwide are attributable to NCDs,
nearly half of which are premature and in individuals of working age.1
Despite significant global commitments2 and the fact that NCDs
are eminently preventable,3,4 effective solutions to reducing NCDs5-8
largely continue to elude the public health community. Two issues make
responding to this challenge particularly difficult. The first is the public
health community’s mainly narrow approach to solving public health
problems (such as NCDs). The second issue is the involvement of cor-
porate actors in public health policymaking. This article addresses the
first issue by exploring the value of a systems approach to understanding
NCDs as an emergent property of a complex system. It addresses the
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second issue by focusing on the influence of commercial actors within
that system.
Narrow Public Health Approaches
to Solving Public Health Problems
The etiology of NCDs is complex and multifactorial, influenced by a
range of individual, social, environmental, political, cultural, economic,
and commercial determinants. Although this is widely acknowledged
in the literature,9 as is the need for more “upstream” solutions (such as
alcohol pricing policies10 and policies to address the nutrition transi-
tion and corresponding double burden of disease),11 the predominant
response continues to be isolated, “downstream” interventions. These
tend to focus on education and individual-level behavior change despite
the evidence that most of these approaches are effective only in the
short term.12 The public health community continues to rely on down-
stream interventions because evidence of their effectiveness is more read-
ily available than that for upstream interventions, a situation known as
the “inverse evidence law.”13 Interventions at the population level (eg,
national policies or large-scale area-based changes) are more likely to
affect multiple health and nonhealth outcomes.14 However, their scale
and other ethical and methodological challenges in their evaluation
almost always militate against the conduct of so-called gold-standard
approaches to evidence generation such as randomized controlled trials
(RCTs).15 Thus other methodological approaches, such as evaluations of
natural experiments, are more often used.16 Common to both designs
is the idea of a counterfactual: attempting to isolate the causal effect of
a single intervention on a single outcome of interest, holding all other
factors constant. The complex etiology of NCDs, however, creates an
epistemological challenge for evaluating programs designed to reduce
them. Given that NCDs are the result of a complex set of factors3 oper-
ating at several levels, from the individual to the societal, there are 2 key
problems for which traditional evaluation approaches do not adequately
account: complex causality and multiple outcomes.
Complex Causality
Commercial influences, international trade agreements, agricultural and
food policies, and other macrolevel factors may have both direct and
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indirect influences on NCDs as well as contributory factors such as
smoking, inactivity, and obesity. These influences operate through long
and complex causal pathways. They can also interact with one another
and their contexts, with implications for interventions at different levels.
For these reasons, direct causal pathways between, for example, the
marketing of sugar-sweetened beverages to children and child obesity
outcomes are difficult to identify. Similarly, causality in relation to the
effectiveness of specific interventions (eg, restrictions on advertising to
children) is more difficult to show than for individual interventions that
are amenable to RCTs.
Multiple Outcomes
While it is plausible to focus on, for example, body mass index (BMI)
or weight as one primary outcome measure when trying to reduce the
burden of NCDs, changes in health outcomes are not the intended, and
typically are not the sole, goal of most policies that have the potential to
influence the upstream determinants of NCDs. For example, the agricul-
tural policy of the European Union (EU) has a wide range of goals, such
as producing food, protecting rural communities and the environment,
protecting farmers’ incomes, and promoting employment. Nevertheless,
the EU’s agricultural policy is also likely to have an important if distant
effect on health outcomes. Evaluating the effectiveness of interventions
based on a single or even a few primary health outcomes may therefore be
misleading, particularly because the effects on public health outcomes
may bemediated through diverse nonhealth pathways. Conducting eval-
uations from a systems perspective, therefore, offers an opportunity to
address this evidence gap, as such evaluations can incorporate the assess-
ment of change in a wider range of health and nonhealth outcomes. We
next describe both what this might involve in practice and the potential
it offers for understanding the commercial determinants of health.
The Involvement of Corporate Actors
in Public Health Policymaking
The second challenge in responding positively to NCDs (and the fo-
cus of this article) lies in the involvement of corporate actors in pub-
lic health policymaking. This has been characterized by a shift in
focus to multiple (sometimes overlapping) decision-making forums
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within a complex system of multilevel governance. The range of actors
participating in decisionmaking has diversified,17 echoing broader shifts
in the nature of government.18,19 The adverse influence of corporate
actors in public health policy—specifically in areas such as alcohol,
tobacco, food and nutrition, and gambling—is well documented and
there is a coherence of approaches across these industries.18,20-22 Un-
healthy commodity industries (UCIs) are defined as industries in which
a significant share of their product portfolio comprises unhealthy prod-
ucts including tobacco, alcohol, energy-dense and low-nutrient foods
and beverages, and gambling services. Although the gambling industry
has received less attention than other UCIs as a driver of NCDs, it is
expanding rapidly and is associated with other risk factors for NCDs (eg,
alcohol consumption).23,24 Disabilities associated with gambling harms
are now comparable to those associated with alcohol misuse, with even
low-level gambling being potentially harmful.25
The strategies and approaches that UCIs use to promote their prod-
ucts and choices that are detrimental to health26 include strategies often
categorized as “market” and “nonmarket” components,27 although the
distinction between them is increasingly debatable. In addressing the
dual forces of increasing globalization and corporations’ tailoring of
global strategies to local conditions, transnational corporations have be-
come expert at “glocalization,” or the creation of demand by applying a
tailored “marketing mix” (including price, placement, promotions, and
product), leveraging their global brands, implementing different activ-
ities in different market types, and segmenting the target market.28,29
Nonmarket strategies, whose purpose is to create additional value for
businesses by improving overall perceptions of the business,20,21,30 aim to
leverage political and social influence, so-called soft power, to influence
policy.21 These strategies include influencing the creation of evidence;
questioning the effectiveness of statutory regulation and emphasizing
self-regulation and public-private partnerships; publicly discrediting
researchers; focusing on individual responsibility; attempting to frame
the extent and nature of alcohol-related harms and the relevant solu-
tions; and forming alliances with other sectors or the public to give
the impression of larger support for the industry’s position.30,31 Miller
and Harkins further explain the scope of corporate political influence by
warning that “it is no longer enough to think about corporations only as
attempting to influence policy. In reality, much decision-making power
has been directly devolved to them while corporations are increasingly
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‘internal’ to the State.”18 This is a fundamental point: public health
actors typically continue to treat corporations as external to the state be-
cause they have a fiduciary responsibility to maximize shareholder value
through the pursuit of profit, an end goal different from those of public
policy. However, this fails to recognize “the corporatization of public
health,”32 the fact that corporations are increasingly part of the fabric of
public health policymaking, as just explained. This is compounded by
the fact that many government activities have now devolved to arm’s-
length organizations, including those delivered by corporations, with
the potential for attendant conflicts of interest.33-35
The involvement of UCIs in public policy, in particular via public-
private partnerships and self-regulation mechanisms, could be an effec-
tive way of improving NCDs, although a growing body of literature
consistently demonstrates that they are not or that they are unlikely to
do so; they are usually supported by a weak evidence base while protect-
ing business interests.10,36-47 Against this, UCIs reject the most effective
interventions to improve public health (including changes in pricing,
promotion, or supply that would affect sales and profits). Moreover, self-
regulatory regimes and corporate social responsibility (CSR) programs
help build constituencies across sectors and beyond core business activ-
ities and are thus very effective strategies to create consumers’ brand
associations, increase brand recall, and shape purchase intentions.48 Fi-
nally, strategies that influence the creation or presentation of evidence
have been shown to moderate guidelines (eg, dietary guidelines), divert
attention and resources away from effective research, and undermine in-
dependent evidence.49-51 These results lead to fundamental conflicts of
interest, compromising public health goals.26,52
Taking a Systems Approach
There is therefore an urgent need for a plurality of public health ap-
proaches to NCD prevention, integrating mixed methods from a variety
of sources and disciplines53 to understand how our environments—or
systems—might react to change or become more health promoting.
Calls for a complex systems approach—one taking account of systems
phenomena, such as interconnections between stakeholders, interven-
tions, and their settings; and self-organizing and emergent behavior,
nonlinearity, and feedback loops—are becoming increasingly common
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in public health53-57 and, more specifically, in addressing the impact of
UCIs.58 Such an approach has the potential to encourage the integration
of mixed methods from a variety of sources and disciplines, including
quantitative and qualitative traditions;53 to promote a better under-
standing of the wider political, institutional, and cultural context in
which health outcomes, risk factors, and behaviors are embedded; and to
help identify potential leverage points for pro–public health interven-
tions in the system. A systems approach would facilitate shifting away
from the predominantly isolated intervention thinking and to regaining
traction in the governance of public health change by understanding
where power currently resides.59 Pursuing a systems approach can thus
allow action at the most crucial points in the system as well as systemic
interventions that improve public health.
A complex system may be characterized by its heterogeneity (with
various actors and structures at different levels); its dynamic, interactive,
and adaptive nature (its ability to respond to or resist external changes,
or changes in the interacting parts); and its emergent properties (arising
through interactions between processes or factors that alone do not ex-
hibit such properties).55,56,60 A “high-functioning” or embedded system
is said to have a combination of 3 important characteristics: (1) re-
silience, (2) self-organization or adaptivity, and (3) hierarchy.60 Resilience
is a measure of a system’s ability to survive and persist in a variable
environment, its ability to bounce or spring back into shape after being
pressed or stretched. Adaptivity, or self-organization (a system’s capacity
to make its own structure simpler or more complex, to diversify and
evolve in response to external pressures), and hierarchy (arrangements
of subsystems to facilitate the system’s functioning) further contribute
to a system’s resilience.60 A system that is dynamic, interactive, and
adaptive may be better able to respond to or resist external changes or
changes in the interacting parts. It is useful to consider these properties
when thinking of a public health intervention whose objective is usually
to change someone’s behavior. If the system, or its subsystems (eg, the
food system), that a public health intervention is trying to change is
so resilient that it can absorb that intervention and “spring back into
shape,” it may in this way render the intervention ineffective.
While NCDs are often conceptualized in terms of individual-level
risk factors, we argue that they should be reframed as the product of a
complex system, having been shaped by a set of interrelated systems like
the processed-food and alcohol systems. Thus the involvement of UCIs
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in public health policymaking can itself be thought of as a complex
intervention often made up of many interacting components operating
at different levels and with different possible outcomes and mechanisms
and implemented in different contexts.
This complex intervention presents challenges and opportunities for
using innovative methods and approaches to describe, analyze, and eval-
uate the various ways in which UCIs are involved in public health
policies and also the (health and nonhealth) impact of that involve-
ment. Employing a systems thinking approach could help conceptualize
a public health issue as embedded in the wider political, economic, in-
stitutional, and cultural systems; reveal the underlying characteristics
and relationships of systems; and show how they interrelate to produce
outcomes. Systems thinking stipulates that understanding relationships
among components of a system necessitates acknowledging the system’s
context and culture. It also enables moving away from “factors thinking”
(listing factors that may influence a result) and “intervention thinking”
(which recommends solutions based on isolated, discrete interventions)
toward “operational thinking” (understanding how interventions work
in combination and interact with their context).
Despite these advantages, the translation of systems thinking into
practical applications in public health is challenging, and existing ap-
plications remain on the whole at the theoretical level.54,56 This article
theorizes that the effect of UCIs’ products and strategies on NCDs is
greater than the sum of its parts. In other words, corporate influence is
not just a question of linear relationships between a marketing strat-
egy and individual consumption, or between corporate presence at a
scientific conference and public health research agendas. Instead, it is a
question of how these strategies come together to create a system that
is resilient to public health interventions through its capacity to adapt
and diversify.
Applying a Systems Thinking
Framework to NCDs’ Commercial
Determinants
Next we explore the systems thinking framework proposed by Donella
Meadows61 and examine how it can be used to analyze the commercial
determinants of NCDs, and, specifically, how UCIs influence public
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health policy. Meadows suggests that a system can be conceptualized
as a set of elements interconnected in such a way that they produce
their own pattern of behavior over time and with a specific function or
purpose.60 She proposes 12 leverage points in a system, organized into
(1) elements, (2) interconnections, and (3) purpose.
Elements include such tangible components as individual citizens,
individuals’ skills, and a system’s physical structures.56,60 The elements
of a system are the most visible or concrete and thus are the easiest and
most obvious point of intervention. This is therefore where most public
health interventions occur;56 yet focusing on the system’s elements is
often the least effective place in which to bring about change.61
Meadows explains the importance of interconnections by referring to
the following saying: “You think that because you understand ‘one’ that
you must therefore understand ‘two’ because one and one make two.
But you forget that you must also understand ‘and.’ ” Interconnections
include physical flows (shifting objects from point A to point B) and
information flows (rules, instructions), characterized by balancing or
reinforcing feedback loops, and self-organization. These are, for exam-
ple, the governance, economics, and sustainability of alcohol processing.
Understanding these interconnections, that is, the structures, interde-
pendencies, and feedback within a system, can help the public health
community better identify damping effects and blockages in the sys-
tem, as well as barriers to effective action, and clarify where actions
and changes in structure need to occur, thus leading to significant and
enduring improvements.62
Finally, a system’s purpose or function can be characterized by its goals
and paradigms and include both intended responses (eg, a soft drinks
company aims to increase soft drink consumption; a government health
department aims to improve health outcomes) and unintended conse-
quences. A system’s operation at the level of the paradigm refers to the
system’s most deeply held beliefs that drive its goals, rules, and struc-
tures. Although it may be difficult for the public health community to
intervene at this level, it can be very effective.56 This is, for example,
the level at which advocates were trying to act when working on the
successful introduction of minimum unit pricing for alcohol in Scotland,
consistently framing alcohol policy as a multisectoral public health issue
requiring a whole-population approach.63
How a system and its components are defined is in many ways deter-
mined by one’s perspective and interests. The predominant perspective
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will depend on how the elements are portrayed; that is, who are presented
as legitimately the predominant actors, as well as their relative power
within the system; whether evidence concerning the health impact of
products is contested; and how interconnections are formed (who decides
on and influences policy). Whether a system’s core function or purpose, for
instance, is regarded as production and sales (of a commodity) or a pop-
ulation’s well-being and health depends on whether a production and
trade perspective (economic gain) or a health-driven perspective (health
gain) is dominant. In turn, the definition of the system and its compo-
nents and how debates around it are framed determine the interventions
and solutions that are considered.
A Worked Example: Applying the Systems
Thinking Framework to Analyzing Commercial
Determinants of NCDs
A systems approach can begin with the development of a conceptual
model to encode “our beliefs about the networks of causes and effects that
describe how a system operates, along with the boundary of the model
(which variables are included and which are excluded) and the time
horizon we consider relevant.”64 Nonetheless, most conceptual models,
like that in Figure 1, are visually linear, illustrating the effects of certain
factors along a pathway rather than showing and characterizing the
interactions between factors. Such causal pathways are certainly useful
in clarifying the sectors and factors of interest and also as communication
tools. The main shortcoming of such illustrations is that they do not
necessarily allow for thinking through how these sectors and factors
might interact to produce an outcome.
We next offer an example of a more complex, nonlinear, preliminary
conceptual model of an “NCD-genic” system, specifically focused on
NCDs’ commercial determinants (Figure 2). Models like this can be
built through approaches such as qualitative systems dynamic model-
ing, an innovative approach to understanding the nonlinear behavior of
complex systems66 that has been successfully employed, for example,
to analyze housing as a complex system by mapping the links between
environmental, economic, social, and health outcomes66 or to analyze
urban water management.67 Visualizing the system with the help of
a causal loop diagram (CLD)68 can help unpack the individual system
components and interconnections between them. CLDs can help create
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a concise narrative about a particular problem; they can be thought of
as “sentences” constructed through the identification of key variables in
a system (the “nouns”) and the explanation of the causal relationships
between them via links (the “verbs”).69
This model is a deliberate attempt to begin to display NCD-
related system complexity, but it is by no means comprehensive. For
example, a more complete version would contain advertising prod-
ucts to the public, the direct lobbying of politicians, and alternative
solutions apart from public-private partnerships, such as education.
All the relationships or interactions the model depicts are based on
evidence.
This conceptual model—while arguably more complex and less easily
accessible than Figure 1—allows the depiction of both market and
nonmarket strategies, as well as the highlighting of sectors or factors
(like the unintended consequence of unsafe tap water) that otherwise
would not be considered, even though they play an important role
in NCDs. Developing such a model can thus help visualize systems’
underlying characteristics and relationships and show how they interact
to produce an outcome. Through this lens, NCDs can be conceptualized
as an emergent property of a complex system, rather than the results of
individual factors, like lifestyle choices.
Visualizing the complex system can also help unpack its individual
components (ie, the system’s elements, interconnections, and functions),
understand how they might contribute to or help mitigate NCDs, and
identify the key research questions and methods that can help analyze
them.
Elements of an NCD-Genic System
Although the elements of a system are the most visible or tangible, and
thus the easiest point of intervention, they often are the least effective
place to intervene.61 We will use the marketing of Coca-Cola as an ex-
ample. It is rarely the product itself on which consumers are made to
focus, but rather the experience the product is meant to bring the con-
sumer: “Ads never showed what was in Coca-Cola, but instead what
Coca-Cola was in: pleasant, poignant scenes of everyday life.”75 Typi-
cally, public health research and programs try to redress the balance by
emphasizing the product itself to demonstrate that it is bad for health
if consumed in excess. These approaches, however, fail to acknowledge
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the emotional connection that the advertisers have made between the
drink and imagined positive life experiences. As a result, consumers are
rarely interested in the physical properties of the product itself, includ-
ing any of its negative properties. Although knowing and describing
the elements of a system will not explain the system’s behavior,60 it is
nonetheless essential to identify (qualify and quantify) the elements at
play in order to be able to think through what interconnections might
exist and why. In Figure 2, elements might include the range of actors,
the latest evidence relating to market access and trade, consumption
patterns, scientific research on the impact of consumption, as well as the
physical arrangements to facilitate trade and consumption. Policies and
programs may also be considered as elements of the system. Methods
to use when identifying a system’s elements and gauging their impor-
tance to the system include stakeholder mapping to identify key actors;
historical analyses to understand context and culture; policy analysis
to understand the scope and nature of policy commitments; analysis of
industry documents and narratives via media analyses; RCTs of relevant
interventions; national surveys of consumption and behaviors; systematic
reviews and meta-analyses; and logic models.
How UCIs Interact With Others to Shape an
NCD-Genic System
How can we best analyze how a system’s elements interact and therefore
how to intervene effectively? Key points include understanding feed-
back loops (reinforcing and balancing), information flows, rules, self-
organization (the power to add, change, or evolve system structure), and
power relations. A good example of the last is UCIs’ building constituen-
cies, that is, forming alliances with others beyond their core business to
create an appearance of larger support for their position.20,30,76 Sports
sponsorship is a common example, with gambling companies sponsor-
ing half of the Premier League team shirts.77 Other examples include
Diageo’s financial involvement in the National Organisation for Foetal
Alcohol Syndrome.78
Using the feedback loop as an example of a mechanism by which
change in a variable is either amplified (positive or reinforcing feedback)
or lessened (negative or balancing feedback),79 feedback mechanisms
can be used to reinforce feedback between behavioral and environ-
mental characteristics. For example, the promotion of healthier diets
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might in turn create a wider demand for healthy foods.55 A reinforcing
feedback loop enhances whatever direction of change is imposed on a sys-
tem, and it can also have detrimental effects.79 Drawing on the example
presented in Figure 2, poor access to safe tap water can contribute to in-
creased soft drink consumption, which, in turn, might lead to decreased
tap water consumption and less public investment in clean tap water. An
unintended consequence might therefore be the increased marketing of
bottled water by soft drink companies in the area. This also has the un-
intended consequence of encouraging a view in the population that the
main way to protect one’s family’s health is to buy safe commercial prod-
ucts in the marketplace rather than relying on collective solutions such
as supplies of safe tap water. Thus, investigating the interconnections
between the system’s elements can provide invaluable insights into non-
linear and unanticipated effects and can help inform themost appropriate
action.55,56 Table 1 outlines some of the key questions to ask when try-
ing to understand a system’s interconnections and what methods to use
to do so.
How UCIs Operate at the Level of the
Paradigm to Influence a System’s Purpose
A system’s purpose is the least tangible of its components, as it “is not
necessarily spoken, written, or expressed explicitly.”60 Although often
characterized by goals and paradigms, a system’s purpose or function
is best deduced from its behavior rather than from its stated goals (eg,
a government health department may have a stated aim to improve
population health outcomes but allocates little money or commitment
to that goal).60 An effective analysis of a system’s purpose or function
thus includes an observation of its goals, its intended and unintended
responses, and its outcomes. From a public health perspective, systems
should fundamentally be designed to improve population health,92 with
governments responsible for driving health-protecting policies and pre-
ventive approaches. Nevertheless, and understandably, these views are
seldom shared by all actors involved in shaping the system. The assump-
tion that health is a central concern for all involved is faulty, because
governments negotiate pressures and demands from a range of sectors to
deliver a range of goals.
A powerful example of how aUCI operated at the level of the paradigm
to influence the system’s deepest held beliefs (globally, one could argue)
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Table 1. Understanding Interconnections in a System
Questions to ask when
aiming to understand
interconnections in a system Potential methods
What are the causal
maps/pathways/processes,
and how can they help or
hinder an intervention?
Logic models80
Tracer methods81,82
Group model building83
Causal loop diagrams (as an analytic
tool)68
What structures are in place?
What processes occur? What
interests are at play?
Social network analysis84,85
Stakeholder analysis86,87
Economic game theory
Analysis of industry documents,
tactics, and strategies88,89
Analysis of policy documents
Media analyses90
What are the feedback loops?
How does the system
constrain/suppress, and/or
potentiate the effects of an
intervention on the
outcomes of interest?
Simulation-based approaches such as
Agent-based models
Longitudinal analysis
Monitoring trends over time
How “resilient” is the system
to change? Does the system
“absorb” interventions? Is
the system resistant to
change?
Policy evaluations37,91
Analysis of industry documents,
tactics, and strategies
is again the symbolism portrayed by Coca-Cola, embodying Western
open-market values, freedom, happiness, youthful culture, and
democracy.93 There are countless examples of how Coca-Cola has man-
aged to achieve this. One reported by the company itself is its decision
to distribute the soft drink to East Germans a few hours after the Berlin
Wall came down in 1989, signaling the beginning of a new era94 and
market opportunities. It is reported that in the first week after the fall
of the Berlin Wall, 2 million people “drank a toast to freedom with a
Coke.”94 The soft drink is portrayed as transcending social and cultural
boundaries in a familiar yet aspirational way. Andy Warhol, whose art
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often critiqued consumerist values, explained the supposed democratiz-
ing power of Coca-Cola:
You can be watching TV and see Coca-Cola, and you know that the
President drinks Coke, Liz Taylor drinks Coke, and just think, you
can drink Coke, too. A Coke is a Coke and no amount of money
can get you a better Coke than the one the bum on the corner is
drinking. All the Cokes are the same and all the Cokes are good. Liz
Taylor knows it, the President knows it, the bum knows it, and you
know it.95
When Coca-Cola entered the Soviet Union around 1990, Pepsi had
already been there for decades as a result of an early trade agreement with
that country. It is said that Pepsi’s early presence backfired, however,
because it represented the fallen Soviet system; by contrast, Coca-Cola
was able to portray itself as representing freshness and liberation and
rapidly overtook Pepsi throughout most of Eastern Europe.96 When
thinking of intervention success, this example illustrates the importance
of focusing on understanding the context (shifting political situation,
what it implies culturally, and how “deepest held beliefs” may actually
be changing rapidly) instead of focusing on the product itself (the taste of
Pepsi or, in the case of a public health intervention, a nutrition education
message on the need to curb the consumption of sugary drinks).97
When assessing a system’s function or purpose, one can explore the
behaviors (vs statements) of key actors; how an industry or brand aims
to shape or tap into beliefs, knowledge, attitudes, behaviors; and why
and in what target group(s) beliefs, knowledge, attitudes, and behaviors
are shaped.
Discussion
The Value of Taking a Systems Approach
Drawing on Meadows’s systems thinking framework, we examined how
a systems perspective can be applied to analyze commercial determinants
of NCDs and specifically how UCIs influence public health policy. We
demonstrated how taking a systems approach to understanding com-
mercial determinants of NCDs helps identify more clearly how UCIs
market their products, gain agency over policy and politics, and le-
gitimize their increasing presence in public health decision making.
A systems approach also shows that the effect of a given intervention
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depends on other conditions in the system as well as the interconnections
between the elements of that system.55 This approach also stipulates that
understanding these interconnections requires acknowledging the sys-
tem’s context and culture.55,56,97
Applying a systems approach to addressing NCDs clearly shows that
such a complex health issue is embedded in the wider economic, po-
litical, institutional, and cultural system rather than merely being the
result of individual lifestyle choices. Current public health research still
concentrates mainly on a system’s elements rather than the interconnec-
tions within it, and this is beginning to reveal its intrinsic limitations.
Changing individual variables rarely changes a system’s behavior.60 Ul-
timately the central goal of public health actions will be to achieve
sustainability of public health gains in the context of a dynamic system,
and a systems approach can support this goal: sustainability includes the
intervention’s adaptability, the persistence of changes made, the ongo-
ing adoption of new changes, scalability (diffusion across settings), and
reach (diffusion across population groups, crossing cultural and other
boundaries).98,99
We demonstrated that a systems analysis may start with producing
a worked example of a causal loop diagram of the NCD-genic system,
which includes knowledge and assumptions about the fundamental pro-
cesses that may be involved. The development of a conceptual model
of the system can be a prelude to developing new evidence-based inter-
ventions and evaluating them, evaluating other changes in the system,
like the introduction of new policies that might—intentionally or not—
produce changes in rates of NCDs, or synthesizing and understanding
existing evidence to direct further interventions and future research. It
is important to note that there are several systems approaches and re-
lated methods, many of which are starting to be applied to public health
policy analysis.54
A systems thinking approach can therefore help clarify the com-
plexities of NCDs by drawing out their interpersonal, community, and
intersectoral dynamics for generating solutions; generating new hy-
potheses and identifying gaps in empirical data; analyzing intended and
unintended consequences; and identifying the networks and actors in-
fluencing decision making in health as well as the policy levers that can
be used to address public health problems.57 For example, this approach
can be a powerful mechanism to understand effective countervailing
forces against UCIs’ influence in public health policy, such as the crucial
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role of civil society organizations in the imposition of an effective soft
drink tax in Mexico.100
Explicit and early recognition of the role of UCIs in future causal
models of NCDs and in the development of policies and regulatory
frameworks (such as the Framework Convention on Tobacco Control)101
will be essential. AsGreen noted, faulty thinking leads to failed planning
and action.102 Moreover, developing ways to manage UCIs’ influence
on policies through long-term mechanisms, which transcend political
cycles, will be an essential strategy.103
Conclusion
This article contributes to the growing literature on applying systems
thinking to public health problems. Applying a systems lens to a com-
plex example such as the commercial determinants of NCDs illustrates
its potential to help avoid linear thinking and to identify intercon-
nections and complexities as a starting point for further research and
action. The questions and methods we proposed are meant to be useful
for researchers by identifying the types of knowledge that help char-
acterize a system and how its components work together to generate
NCDs (or other complex public health problems). Principles of systems
thinking may be applicable to NCDs as well as to other complex prob-
lems, and they should now be tested and refined for other public health
challenges.
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